Key result
Systemic chemotherapy using non-cardiotoxic drugs in divided doses led to a complete response in a patient with primary pericardial lymphoma, who remained disease-free at 30 months.
Case Report (n=1)
Systemic chemotherapy using non-cardiotoxic drugs in divided doses can lead to complete response and long-term disease-free survival in patients with primary pericardial lymphoma.
No takes yet. Share an insight, caveat, or question.
May warrant consideration in primary pericardial lymphoma; leaves open efficacy of non-cardiotoxic regimens pending prospective data.
Pavlidis et al. (1994) conducted a case report in Primary lymphoma of the pericardium (n=1). Systemic chemotherapy was evaluated on Response to treatment and disease-free survival. Systemic chemotherapy using non-cardiotoxic drugs in divided doses led to a complete response in a patient with primary pericardial lymphoma, who remained disease-free at 30 months.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: